NURX Insider Trading Activity and SEC Form 4 Filings
NURX insider trading summary
No open-market insider purchases or sales of Nurx Pharmaceuticals, Inc. (NURX) have been reported on SEC Form 4 in the past 12 months.
Latest NURX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 10, 2008 | Sharyar Baradaran | Director | Buy | $52K (95,000 @ $0.55) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.